Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues

被引:16
|
作者
Turman, Cheri M.
Hatley, Jade M.
Ryder, Daniel J.
Ravindranath, Vijayalakshmi
Strobel, Hen W.
机构
[1] Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Natl Brain Res Ctr, Manesar, Haryana, India
关键词
alternative splicing; brain CYPs; cytochrome P450; drug metabolism;
D O I
10.1517/17425255.2.3.399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human cytochrome P450 (CYP) superfamily of enzymes regulate hepatic phase 1 drug metabolism and subsequently play a significant role in pharmacokinetics, drug discovery and drug development. Alternative splicing of the cytochrome CYP gene transcripts enhances gene diversity and may play a role in transcriptional regulation of certain CYP proteins. Tissue-specific alternative splicing of CYPs is significant for its potential to add greater dimension to differential drug metabolism in hepatic and extrahepatic tissues, such as the brain, and to our understanding of the CYP family. This review provides an overview of tissue-specific splicing patterns, splicing types, regulation and the functional diversities between liver and splice variant CYP proteins and further explores the relevance of tissue-specific alternative splicing of CYPs in the nervous system.
引用
收藏
页码:399 / 418
页数:20
相关论文
共 50 条
  • [1] Diversity of common alternative splicing variants of human Cytochrome P450 1A1 and their association to carcinogenesis
    Bauer, Mario
    Herbarth, Olf
    Rudzok, Susanne
    Schmuecking, Eike
    Mueller, Andrea
    Aust, Gabriela
    Graebsch, Carolin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (01) : 211 - 218
  • [2] Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug Discovery
    Pan, Shu-Ting
    Xue, Danfeng
    Li, Zhi-Ling
    Zhou, Zhi-Wei
    He, Zhi-Xu
    Yang, Yinxue
    Yang, Tianxin
    Qiu, Jia-Xuan
    Zhou, Shu-Feng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07):
  • [3] Alternative Sampling Strategies for Cytochrome P450 Phenotyping
    De Kesel, Pieter M. M.
    Lambert, Willy E.
    Stove, Christophe P.
    CLINICAL PHARMACOKINETICS, 2016, 55 (02) : 169 - 184
  • [4] Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria
    Bhagwat, SV
    Boyd, MR
    Ravindranath, V
    BIOCHEMICAL PHARMACOLOGY, 2000, 59 (05) : 573 - 582
  • [5] Advances in Human Cytochrome P450 and Personalized Medicine
    Chen, Qi
    Zhang, Tao
    Wang, Jing-Fang
    Wei, Dong-Qing
    CURRENT DRUG METABOLISM, 2011, 12 (05) : 436 - 444
  • [6] Expression and function of cytochrome P450 in brain drug metabolism
    Meyer, R. P.
    Gehlhaus, M.
    Knoth, R.
    Volk, B.
    CURRENT DRUG METABOLISM, 2007, 8 (04) : 297 - 306
  • [7] High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli
    Iwata, H
    Fujita, K
    Kushida, H
    Suzuki, A
    Konno, Y
    Nakamura, K
    Fujino, A
    Kamataki, T
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (08) : 1315 - 1325
  • [8] Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3
    Kim, Dong-Hyun
    Kim, Keon-Hee
    Kim, Dooil
    Jung, Heung-Chae
    Pan, Jae-Gu
    Chi, Youn-Tai
    Ahn, Taeho
    Yun, Chul-Ho
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 63 (3-4) : 179 - 187
  • [9] A patent review on the development of human cytochrome P450 inhibitors
    Francis, Sheena
    Delgoda, Rupika
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2014, 24 (06) : 699 - 717
  • [10] Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system
    Ingelman-Sundberg, Magnus
    Sim, Sarah C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (01) : 90 - 94